Showing results (1651-1660 of 9,924) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|November 1, 1988
Intravenous immunoglobulin may lessen all forms of infection in patients receiving allogeneic bone marrow transplantation for acute lymphoblastic leukemia: a pediatric oncology group studyJ Graham-Pole, B Camitta, J Casper, et al.
Bone Marrow Transplantation|November 1, 1988
A model system illustrating the isolation and enrichment of a rare population of tumour cells in bone marrowF M Gibson, P A Liberti, J T Kemshead
Bone Marrow Transplantation|November 1, 1988
Laboratory control in predicting clinical efficacy of T cell-depletion procedures used for prevention of graft-versus-host disease: importance of limiting dilution analysisE Marciniak, E H Romond, J S Thompson, et al.
Bone Marrow Transplantation|November 1, 1988
Simultaneous infusion of high-dose cytosine arabinoside with cyclophosphamide followed by total body irradiation and marrow infusion for the treatment of patients with advanced hematological malignancyF B Petersen, F R Appelbaum, C D Buckner, et al.
Bone Marrow Transplantation|December 7, 2018
A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemiaYongxian Hu, Jiasheng Wang, Guoqing Wei, et al.
Bone Marrow Transplantation|December 7, 2018
Treatment of Epstein-Barr virus associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation with intrathecal donor lymphocyte infusionJuanjuan Zhao, Yingling Zu, Lijie Han, et al.
Bone Marrow Transplantation|December 12, 2018
Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMTYoshihiro Inamoto, Igor Petriček, Linda Burns, et al.
Bone Marrow Transplantation|December 12, 2018
Impact of low-dose irradiation and in vivo T-cell depletion on hematopoietic stem cell transplantation for non-malignant diseases using fludarabine-based reduced-intensity conditioningKatsutsugu Umeda, Hiromasa Yabe, Koji Kato, et al.
Bone Marrow Transplantation|December 12, 2018
Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDSGheath Alatrash, Kelly M Kidwell, Peter F Thall, et al.
Bone Marrow Transplantation|December 4, 2018
Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantationJuliane Grimm, Marius Bill, Madlen Jentzsch, et al.
Pageof 993